-
- David W. Beier . . .former head of Government Affairs
for Genentech, Inc., . . .now chief domestic policy advisor to Al Gore,
Vice President of the United States.
-
- Linda J. Fisher . . .former Assistant Administrator of
the United States Environmental Protection Agency's Office of Pollution
Prevention, Pesticides, and Toxic Substances, . . .now Vice President of
Government and Public Affairs for Monsanto Corporation.
-
- Michael A. Friedman, M.D. . . former acting commissioner
of the United States Food and Drug Administration (FDA) Department of Health
and Human Services . . .now senior vice-president for clinical affairs
at G. D. Searle & Co., a pharmaceutical division of Monsanto Corporation.
-
- L. Val Giddings . . . former biotechnology regulator
and (biosafety) negotiator at the United States Department of Agriculture
(USDA/APHIS), . . .now Vice President for Food & Agriculture of the
Biotechnology Industry Organization (BIO).
-
- Marcia Hale . . . former assistant to the President of
the United States and director for intergovernmental affairs, . . .now
Director of International Government Affairs for Monsanto Corporation.
-
- Michael (Mickey) Kantor. . . former Secretary of the
United States Department of Commerce and former Trade Representative of
the United States, . . .now member of the board of directors of Monsanto
Corporation.
-
- Josh King . . . former director of production for White
House events, . . . now director of global communication in the Washington,
D.C. office of Monsanto Corporation.
-
- Terry Medley . . . former administrator of the Animal
and Plant Health Inspection Service (APHIS) of the United States Department
of Agriculture, former chair and vice-chair of the United States Department
of Agriculture Biotechnology Council, former member of the U.S. Food and
Drug Administration (FDA) food advisory committee, . . . and now Director
of Regulatory and External Affairs of Dupont Corporation's Agricultural
Enterprise.
-
- Margaret Miller . . . former chemical laboratory supervisor
for Monsanto, . . .now Deputy Director of Human Food Safety and Consultative
Services, New Animal Drug Evaluation Office, Center for Veterinary Medicine
in the United States Food and Drug Administration (FDA).*
-
- Michael Phillips . . . recently with the National Academy
of Science Board on Agriculture . . . now head of regulatory affairs for
the Biotechnology Industry Organization.
-
- William D. Ruckelshaus . . . former chief administrator
of the United States Environmental Protection Agency (USEPA), . . .now
(and for the past 12 years) a member of the board of directors of Monsanto
Corporation.
-
- Michael Taylor . . . former legal advisor to the United
States Food and Drug Administration (FDA)'s Bureau of Medical Devices and
Bureau of Foods, later executive assistant to the Commissioner of the FDA,
. . . still later a partner at the law firm of King & Spaulding where
he supervised a nine-lawyer group whose clients included Monsanto Agricultural
Company, . . . still later Deputy Commissioner for Policy at the United
States Food and Drug Administration, . . . and later with the law firm
of King & Spaulding. . . . now head of the Washington, D.C. office
of Monsanto Corporation.*
-
- Lidia Watrud . . . former microbial biotechnology researcher
at Monsanto Corporation in St. Louis, Missouri, . . .now with the United
States Environmental Protection Agency Environmental Effects Laboratory,
Western Ecology Division.
-
- Jack Watson. . .former chief of staff to the President
of the United States, Jimmy Carter, . . .now a staff lawyer with Monsanto
Corporation in Washington, D.C.
-
- Clayton K. Yeutter . . . former Secretary of the U.S.
Department of Agriculture, former U.S. Trade Representative (who led the
U.S. team in negotiating the U.S. Canada Free Trade Agreement and helped
launch the Uruguay Round of the GATT negotiations), now a member of the
board of directors of Mycogen Corporation, whose majority owner is Dow
AgroSciences, a wholly owned subsidiary of The Dow Chemical Company.
-
- Larry Zeph . . . former biologist in the Office of Prevention,
Pesticides, and Toxic Substances, U.S. Environmental Protection Agency,
. . . now Regulatory Science Manager at Pioneer Hi-Bred International.
-
- *Margaret Miller, Michael Taylor, and Suzanne Sechen
(an FDA "primary reviewer for all rbST and other dairy drug production
applications" ) were the subjects of a U.S. General Accounting Office
(GAO) investigation in 1994 for their role in the U.S. Food and Drug Administration's
approval of Posilac, Monsanto Corporation's formulation of recombinant
bovine growth hormone (rbST or rBGH). The GAO Office found "no conflicting
financial interests with respect to the drug's approval" and only
"one minor deviation from now superseded FDA regulations". (Quotations
are from the 1994 GAO report).
-
- _____
-
- BioDemocracy/Organic Consumers Association Campaigning
for food safety, organic agriculture, & sustainability. 6114 Hwy 61,
Little Marais, MN 55614, E-mail:<mailto:Ronnie@purefood.orgRonnie Cummins
Activist or Media Inquiries: (218) 226-4164, Fax: (218) 226-4157 If you
support this web site, <http://www.organicconsumers.org/member.stmsend
a tax-deductible donation to OCA
|